 | HC Wainwright Trims Otonomy (NASDAQ:OTIC) Target Price to $5.50 marketbeat.com - February 23 at 10:13 AM |
 | Otonomy, Inc. (NASDAQ:OTIC) Director Jay Lichter Sells 321,180 Shares americanbankingnews.com - March 3 at 9:24 PM |
 | Otonomy (NASDAQ:OTIC) Shares Down 10.7% on Insider Selling americanbankingnews.com - March 3 at 6:51 PM |
 | Jay Lichter Sells 173,700 Shares of Otonomy, Inc. (NASDAQ:OTIC) Stock americanbankingnews.com - March 2 at 9:40 PM |
 | HC Wainwright Cuts Otonomy (NASDAQ:OTIC) Price Target to $5.50 americanbankingnews.com - March 1 at 11:29 AM |
 | Looking Back at Bear Market 2020: The Timeless Lesson of One Year Ago Today - Nasdaq nasdaq.com - February 26 at 10:35 PM |
 | Why Earnings Season Could Be Great for Switch (SWCH) - Nasdaq nasdaq.com - February 26 at 10:35 PM |
 | Uptick in Revenues Drive Expeditors (EXPD), High Costs Ail - Nasdaq nasdaq.com - February 26 at 12:34 PM |
 | Are Options Traders Betting on a Big Move in Otonomy (OTIC) Stock? - Nasdaq nasdaq.com - February 26 at 12:34 PM |
 | Insider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 268,118 Shares of Stock americanbankingnews.com - February 26 at 12:42 AM |
|
 | Insider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 311,100 Shares of Stock americanbankingnews.com - February 26 at 12:42 AM |
 | Otonomy to Participate in Three Upcoming Investor Conferences - Yahoo Finance finance.yahoo.com - February 25 at 10:26 AM |
 | Otonomy to Participate in Three Upcoming Investor Conferences finance.yahoo.com - February 25 at 10:26 AM |
 | Otonomy (NASDAQ:OTIC) PT Lowered to $5.50 americanbankingnews.com - February 23 at 10:14 AM |
 | BCLI Slips On FDA Feedback, OTIC Plunges As Ménière's Disease Trial Fails, CLNN On Watch - Nasdaq nasdaq.com - February 23 at 9:13 AM |
 | ROCE Insights For Otonomy - Yahoo Finance finance.yahoo.com - February 23 at 12:02 AM |
 | Otonomy stock loses half its value after disappointing trial results of vertigo treatment - MarketWatch marketwatch.com - February 23 at 12:02 AM |
 | Piper Sandler Lowers Otonomy (NASDAQ:OTIC) Price Target to $5.00 americanbankingnews.com - February 22 at 3:46 PM |
 | Celsion, Citius Pharmaceuticals leads healthcare gainers - Seeking Alpha seekingalpha.com - February 22 at 1:56 PM |
 | ROCE Insights For Otonomy - Benzinga benzinga.com - February 22 at 1:56 PM |
 | ROCE Insights For Otonomy finance.yahoo.com - February 22 at 1:56 PM |
 | Otonomy (NASDAQ:OTIC) Shares Gap Down to $5.39 americanbankingnews.com - February 22 at 9:45 AM |
 | Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease - GlobeNewswire globenewswire.com - February 22 at 8:56 AM |
 | Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease finance.yahoo.com - February 22 at 8:56 AM |
 | Otonomy stock loses half its value after disappointing trial results of vertigo treatment finance.yahoo.com - February 22 at 8:56 AM |
 | Otonomy (NASDAQ:OTIC) Trading Up 8.5% americanbankingnews.com - February 17 at 7:08 PM |
 | Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting - GlobeNewswire globenewswire.com - February 17 at 8:38 AM |
 | Genentech's Faricimab Data Show Promise Of New Treatment For Two Common Causes Of Blindness - Nasdaq nasdaq.com - February 12 at 5:09 PM |
 | Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update marketwatch.com - February 12 at 12:08 PM |
 | Otonomy (NASDAQ:OTIC) Releases Earnings Results, Beats Expectations By $0.02 EPS americanbankingnews.com - February 12 at 10:35 AM |
|
 | Otonomy (OTIC) Q4 2020 Earnings Call Transcript - The Motley Fool fool.com - February 12 at 7:07 AM |
 | Otonomy, Inc. (OTIC) CEO David Weber on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - February 12 at 1:48 AM |
 | Otonomy (OTIC) Q4 2020 Earnings Call Transcript finance.yahoo.com - February 12 at 1:48 AM |
 | Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update finance.yahoo.com - February 11 at 8:47 PM |
 | Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Yahoo Finance finance.yahoo.com - February 4 at 7:44 AM |
 | Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update finance.yahoo.com - February 4 at 7:44 AM |
 | Otonomy Inc bloomberg.com - January 23 at 6:46 PM |
 | Otonomy And Its Efforts At Resurrecting Itself - Seeking Alpha seekingalpha.com - January 12 at 7:27 PM |
 | Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference - Yahoo Finance finance.yahoo.com - January 5 at 8:53 AM |
 | Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference finance.yahoo.com - January 5 at 8:52 AM |
 | Thinking about buying stock in Evolus, Rite Aid, Roku, Marathon Patent Group, or Otonomy? - PRNewswire prnewswire.com - December 17 at 9:17 AM |
 | Otonomy's OTO-413 shows clinical benefit in hearing loss study - Seeking Alpha seekingalpha.com - December 17 at 9:17 AM |
 | Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing Loss finance.yahoo.com - December 17 at 9:17 AM |
 | Is OTIC A Good Stock To Buy Now? - Yahoo Finance finance.yahoo.com - December 16 at 12:40 AM |
 | Is OTIC A Good Stock To Buy Now? finance.yahoo.com - December 16 at 12:40 AM |
 | Is the Options Market Predicting a Spike in Lineage Cell Therapeutics (LCTX) Stock? - Nasdaq nasdaq.com - December 14 at 6:09 PM |
 | Implied Volatility Surging for Energy Fuels (UUUU) Stock Options - Nasdaq nasdaq.com - December 14 at 12:48 PM |
 | JetBlue (JBLU) Initiates Service to Guyana From New York - Nasdaq nasdaq.com - December 14 at 12:48 PM |
 | Otonomy (OTIC) Looks Good: Stock Adds 5% in Session - Yahoo Finance finance.yahoo.com - December 14 at 12:48 PM |
 | Otonomy (OTIC) Looks Good: Stock Adds 5% in Session finance.yahoo.com - December 14 at 12:48 PM |
 | The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street - Yahoo Finance finance.yahoo.com - December 11 at 12:44 PM |